Quest Diagnostics (DGX) Share-based Compensation (2009 - 2026)

Quest Diagnostics has reported Share-based Compensation for 18 years, with the latest figure at $6.0 million in Q2 2026.

• Quarterly Share-based Compensation rose 500.0% year-over-year to $6.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $88.0 million (down 1.12% YoY) and the FY2025 annual result came in at $88.0 million, changed 0.0% from the prior year.
• Share-based Compensation slipped to $6.0 million in Q2 2026 per DGX's latest filing, from $37.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $42.0 million in Q1 2025 and troughed at $1.0 million in Q2 2025.
• A 5-year average of $20.7 million and a median of $19.5 million in 2023 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation tumbled 94.74% in 2025, then surged 500.0% in 2026.
• Over 5 years, Share-based Compensation stood at $22.0 million in 2022, then decreased by 13.64% to $19.0 million in 2023, then jumped by 42.11% to $27.0 million in 2024, then declined by 7.41% to $25.0 million in 2025, then sank by 76.0% to $6.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $6.0 million, $37.0 million, and $25.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.